Form 8-K - Current report:
SEC Accession No. 0000950103-25-006186
Filing Date
2025-05-19
Accepted
2025-05-19 17:22:18
Documents
18
Period of Report
2025-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp228958_8k.htm   iXBRL 8-K 40693
2 EXHIBIT 3.1 dp228958_ex0301.htm EX-3.1 691893
3 EXHIBIT 3.2 dp228958_ex0302.htm EX-3.2 472474
4 EXHIBIT 10.1 dp228958_ex1001.htm EX-10.1 281089
5 EXHIBIT 10.2 dp228958_ex1002.htm EX-10.2 363242
6 GRAPHIC image_001.jpg GRAPHIC 4431
7 GRAPHIC image_002.jpg GRAPHIC 2285
  Complete submission text file 0000950103-25-006186.txt   2324978

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE rprx-20250516.xsd EX-101.SCH 3029
9 XBRL LABEL FILE rprx-20250516_lab.xml EX-101.LAB 34239
10 XBRL PRESENTATION FILE rprx-20250516_pre.xml EX-101.PRE 22368
21 EXTRACTED XBRL INSTANCE DOCUMENT dp228958_8k_htm.xml XML 3691
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 25965148
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)